skip to main content
OSTI.GOV title logo U.S. Department of Energy
Office of Scientific and Technical Information

Title: Newly synthesized hypoxia-mediated drugs as radiosensitizers and cytotoxic agents

Journal Article · · Int. J. Radiat. Oncol., Biol. Phys.; (United States)

Chinese hamster cells in culture were used to compare the radiosensitizing efficiency and cytotoxicity of misonidazole with several 2, 4 and 5 substituted nitroimidazoles. The two subsituted compounds (SR 2508 and SR 2555) are similar to misonidazole in radiosensitizing effectiveness, but are significantly less toxic to hypoxic cells. This reduced cytotoxicity may result from either slower drug penetration or slower removal of non-protein sulfhydryl compounds (NPSH). The compound MJL-1-191-VII* (a 4-nitroimidazole) is a much more effective radiosensitizer than would be predicted from its electron affinity. It appears to sensitize by two mechanisms, the first resulting from its electron affinity and the second a consequence of its rapid removal of endogeneous cellular NPSH; which are naturally occurring radioprotective substances.

DOE Contract Number:
AC02-78EV04733
OSTI ID:
6714989
Journal Information:
Int. J. Radiat. Oncol., Biol. Phys.; (United States), Vol. 8:1
Country of Publication:
United States
Language:
English